Cadre Holdings, Inc. CDRE

FY2025 · ended Dec 31, 2025 · Revenue $610.31M, +7.5% YoY · Filed Mar 10, 2026

Cadre Holdings, Inc. (CDRE) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $610.3 million and net income of $44.1 million. Free cash flow was $56.8 million. As of Sep 30, 2026 it held $63.9 million in cash and investments and $394.3 million in total debt.

Revenue (TTM)
$732.65M
+18.3% vs year-ago TTM
Net income (TTM)
$41.11M
-9.4% vs year-ago TTM
Operating cash flow (TTM)
$88.83M
+34.3% vs year-ago TTM
Free cash flow (TTM)
$76.36M
+24.6% vs year-ago TTM
EPS (TTM)
$0.91
-18.0% vs year-ago TTM
Dividend per share
$0.10
+8.6% vs prior year
Shares outstanding
42.73M
+5.2% vs prior year
Net cash
$-330.39M
as of Sep 30, 2026
Operating margin
10.7%
FY 2026

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
CDRE (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Jacksonville, FL
SEC filer status
, Emerging growth company
SEC CIK
1860543

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$610.3M
$567.6M
$482.5M
$457.8M
$427.3M
Operating income
$67.4M
$66.8M
$56.5M
$16.7M
$51.7M
Net income
$44.1M
$36.1M
$38.6M
$5.8M
$12.7M
Diluted EPS
$1.02
$0.90
$1.02
$0.16
$0.44
Operating cash flow
$63.7M
$31.8M
$73.2M
$46.4M
$40.1M
Free cash flow
$56.8M
$26.1M
$66.5M
$41.9M
$37.3M
Total assets
$770.0M
$652.7M
$431.2M
$392.0M
$311.8M
Total liabilities
$452.2M
$341.2M
$234.0M
$226.1M
$223.2M
Stockholders' equity
$317.8M
$311.5M
$197.2M
$165.9M
$88.6M
Cash and investments
$122.9M
$124.9M
$87.7M
$45.3M
$33.9M
Total debt
$330.6M
$238.8M
$149.0M
$160.6M
$172.9M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K/A Amended current report
Results of operations
Aug 7, 2026 Aug 5, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Material agreement, New debt
Jul 29, 2026 Jul 23, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.